279 related articles for article (PubMed ID: 33792219)
1. Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Ma MCJ; Tadros S; Bouska A; Heavican T; Yang H; Deng Q; Moore D; Akhter A; Hartert K; Jain N; Showell J; Ghosh S; Street L; Davidson M; Carey C; Tobin J; Perumal D; Vose JM; Lunning MA; Sohani AR; Chen BJ; Buckley S; Nastoupil LJ; Davis RE; Westin JR; Fowler NH; Parekh S; Gandhi M; Neelapu S; Stewart D; Bhalla K; Iqbal J; Greiner T; Rodig SJ; Mansoor A; Green MR
Haematologica; 2022 Mar; 107(3):690-701. PubMed ID: 33792219
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
3. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
[TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
[TBL] [Abstract][Full Text] [Related]
5. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
7. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of non-Hodgkin's lymphoma.
Nogai H; Dörken B; Lenz G
J Clin Oncol; 2011 May; 29(14):1803-11. PubMed ID: 21483013
[TBL] [Abstract][Full Text] [Related]
9. B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; Casabonne D; Cerhan JR; Cozen W; Alarcón G; Martínez-Maza O; Brown EE; Bracci PM; Turner J; Hjalgrim H; Bhatti P; Zhang Y; Birmann BM; Flowers CR; Paltiel O; Holly EA; Kane E; Weisenburger DD; Maynadié M; Cocco P; Foretova L; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zheng T; Skibola CF; Clavel J; Monnereau A; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1103-1110. PubMed ID: 35244686
[TBL] [Abstract][Full Text] [Related]
10. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.
Hezaveh K; Kloetgen A; Bernhart SH; Mahapatra KD; Lenze D; Richter J; Haake A; Bergmann AK; Brors B; Burkhardt B; Claviez A; Drexler HG; Eils R; Haas S; Hoffmann S; Karsch D; Klapper W; Kleinheinz K; Korbel J; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Leich E; Loeffler M; Mantovani-Loeffler L; López C; McHardy AC; Möller P; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schlesner M; Scholz I; Stadler PF; Stilgenbauer S; Sungalee S; Szczepanowski M; Trümper L; Weniger MA; Siebert R; Borkhardt A; Hummel M; Hoell JI;
Haematologica; 2016 Nov; 101(11):1380-1389. PubMed ID: 27390358
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Gaidano G; Carbone A; Pastore C; Capello D; Migliazza A; Gloghini A; Roncella S; Ferrarini M; Saglio G; Dalla-Favera R
Blood; 1997 May; 89(10):3755-62. PubMed ID: 9160681
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring.
Esmeray E; Küçük C
Turk J Biol; 2020; 44(1):1-14. PubMed ID: 32123491
[TBL] [Abstract][Full Text] [Related]
13. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
15. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
Glass S; Phan A; Williams JN; Flowers CR; Koff JL
Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
18. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
Altieri A; Bermejo JL; Hemminki K
Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
[TBL] [Abstract][Full Text] [Related]
19. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph [correction of IinterLlymph] analysis.
Cocco P; Vermeulen R; Flore V; Nonne T; Campagna M; Purdue M; Blair A; Monnereau A; Orsi L; Clavel J; Becker N; de Sanjosé S; Foretova L; Staines A; Maynadié M; Nieters A; Miligi L; 't Mannetje A; Kricker A; Brennan P; Boffetta P; Lan Q; Rothman N
Occup Environ Med; 2013 Nov; 70(11):795-802. PubMed ID: 23881218
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
